Eli Lilly and Co.
Scientists at the National Institute for Infectious Diseases in Rome, Italy have published a new study on the immune response of monkeypox virus (MPXV) in individuals who have recovered from the disease. The research team aimed to investigate the T-cell-specific response to MPXV in cured subjects using a whole blood
Pharmaceutical industry
Pfizer, Valeant Pharmaceuticals, and Allergan are among the top gainers in the pharmaceuticals industry today, with the Dow Jones Industrial Average experiencing moderate gains. The Drugs industry currently sits down 0.9% compared to the S&P 500's 0.5% gain. Key Takeaways: * Pfizer is trading up
Pharmaceutical industry
TheFlyOnTheWall.com reported that on December 1, 2015, a summary of notable analyst upgrades was released, including upgrades from 11 leading financial institutions. The upgrades spanned a diverse range of industries and sectors, with companies such as Alcatel-Lucent, Campbell Soup, and Johnson & Johnson receiving positive analyst attention. These upgrades
Pharmaceutical industry
As investors prepare for the earnings onslaught this week, Jim Cramer cautioned against making snap judgments during this time of year, citing that such decisions often turn out to be dead wrong. Cramer identified several key stocks and sectors to watch, including Halliburton, Valeant Pharmaceuticals, and IBM, among others. He
Pharmaceutical industry
The stocks in the drugs industry are experiencing a downturn in the market, with the Dow Jones Industrial Average down 0.7% as of Monday, Oct. 12, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,447 issues advancing vs. 1,507 declining with 153 unchanged.
Pharmaceutical industry
While the causes of Alzheimer's disease are not yet fully understood, researchers have a strong consensus that the buildup of beta amyloid is a key factor in its development. This understanding has led to the pursuit of treatments that target the amyloid protein, with two high-profile clinical trials
Pharmaceutical industry
Researchers from Eli Lilly, Roche, and Biogen presented new data on three Alzheimer's disease drugs at the Alzheimer's Association International Conference, showcasing potential advancements in slowing the progression of the disease. However, several scientists cautioned against placing excessive hope on the incremental progress made by these
Pharmaceutical industry
The health care sector is trading up on Thursday, June 25, 2015, with the Dow Jones Industrial Average (^DJI) gaining 4 points or 0.0% to 17,970. The NYSE advances/declines ratio is at 1,139 issues advancing vs. 1,826 declining with 188 unchanged. Top gainers within the
Pharmaceutical industry
Research and Markets has forecasted that the global depression drugs market will grow at a compound annual growth rate (CAGR) of 5.25% over the period 2014-2019. The growth of the market is expected to be driven by increasing public awareness about depression, which will lead to increased acceptability of
Pharmaceutical industry
Eli Lilly and Company has entered into a clinical trial collaboration with AstraZeneca to evaluate the safety and preliminary efficacy of AstraZeneca's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA (ramucirumab), Lilly's VEGF Receptor 2 antiangiogenic cancer medicine. The Phase I study aims to
Pharmaceutical industry
Post menopausal osteoporosis is a condition characterized by the decline in bone density and increased risk of fractures after menopause. The pipeline for post menopausal osteoporosis has an extensive range of therapeutic options, with several companies actively developing treatments to address this condition. The report "Post Menopausal Osteoporosis -
Pharmaceutical industry
Medical students at the Indiana University School of Medicine are gaining a unique understanding of the pharmaceutical industry through a four-week experiential learning program with Lilly USA. The Medical Student Rotation Program allows third- and fourth-year students to engage in real-world projects and workshops with various departments within Lilly, including
